IQVIA HOLDINGS INC. Accounts Receivable, Allowance for Credit Loss, Current
IQVIA HOLDINGS INC. (IQV) had Accounts Receivable, Allowance for Credit Loss, Current of $49.00 million as of 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2026-05-05
- 2026-03-31: Accounts Receivable, Allowance for Credit Loss, Current $49.00M.
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss, Current $51.00M.
- 2025-09-30: Accounts Receivable, Allowance for Credit Loss, Current $45.00M.
- 2025-06-30: Accounts Receivable, Allowance for Credit Loss, Current $37.00M.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current | Accounts Receivable, Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-03-31 | $49.00M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $51.00M 10-Q · filed 2026-05-05 | |
| 2025-09-30 | $45.00M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $37.00M 10-Q · filed 2025-07-22 | |
| 2025-03-31 | $37.00M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $42.00M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $41.00M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $40.00M 10-Q · filed 2024-07-22 | |
| 2024-03-31 | $30.00M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $34.00M 10-K · filed 2025-02-13 | |
| 2023-09-30 | $27.00M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $28.00M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $33.00M 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $36.00M 10-K · filed 2024-02-15 | |
| 2022-09-30 | $31.00M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $28.00M 10-Q · filed 2022-07-22 | |
| 2022-03-31 | $30.00M 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $33.00M 10-K · filed 2023-02-15 | |
| 2021-09-30 | $30.00M 10-Q · filed 2021-10-22 | |
| 2021-06-30 | $31.00M 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $31.00M 10-Q · filed 2021-04-23 | |
| 2020-12-31 | $34.00M 10-K · filed 2022-02-16 | |
| 2020-09-30 | $30.00M 10-Q · filed 2020-10-22 | |
| 2020-06-30 | $19.00M 10-Q · filed 2020-07-23 | |
| 2020-03-31 | $16.00M 10-Q · filed 2020-04-30 | |
| 2019-12-31 | $16.00M 10-K · filed 2021-02-12 | |
| 2019-09-30 | $13.00M 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $13.00M 10-Q · filed 2019-07-24 | |
| 2019-03-31 | $13.00M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $15.00M 10-K · filed 2020-02-18 | |
| 2018-09-30 | $12.00M 10-Q · filed 2018-10-25 | |
| 2018-06-30 | $14.00M 10-Q · filed 2018-07-27 | |
| 2018-03-31 | $17.00M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $15.00M 10-K · filed 2019-02-19 | |
| 2017-09-30 | $13.00M 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $13.00M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $13.00M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $14.00M 10-K · filed 2018-02-16 | |
| 2016-09-30 | $5.62M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $12.62M 10-Q · filed 2016-07-27 | |
| 2016-03-31 | $4.33M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $2.00M 10-K · filed 2017-02-16 | $2.28M 10-K · filed 2016-02-11 |
| 2015-09-30 | $2.29M 10-Q · filed 2015-10-28 | |
| 2015-06-30 | $1.65M 10-Q · filed 2015-07-29 | |
| 2015-03-31 | $1.56M 10-Q · filed 2015-04-29 | |
| 2014-12-31 | $2.00M 10-K · filed 2016-02-11 | |
| 2014-09-30 | $2.01M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $2.05M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $1.75M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $1.70M 10-K · filed 2015-02-12 | |
| 2013-09-30 | $2.23M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $1.85M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $1.60M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $1.97M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |